N- (E) -Caffeoyldopamine

• Description :

  N- (E) -Caffeoyldopamine is an inhibitor of α-glucosidase that can be purified from Clerodendranthus Spicatus. N- (E) -Caffeoyldopamine shows a 53.73% inhibitory activity againstα-glucosidase. N- (E) -Caffeoyldopamine can be studied in diabetes research[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Glycosidase

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Metabolic Disease

• Purity :

  95.0

• Smiles :

  OC=1C=CC(=CC1O)CCNC(/C=C/C2=CC(O)=C(O)C=C2)=O

• Molecular Formula :

  C17H17NO5

• Molecular Weight :

  315.32

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Zhu, C., et al., (2021) . Bioactivity-guided separation of potential α-glycosidase inhibitor from clerodendranthus spicatus based on HSCCC coupled with molecular docking. Scientific reports, 11 (1), 6914.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, stored under nitrogen)

• Scientific Category :

  Reference compound2

• Clinical Information :

  No Development Reported

• CAS Number :

  [103188-49-4]